Trump administration indefinitely delayed BALANCE, a Medicare pilot to expand GLP-1 weight-loss drug coverage through private insurers, Axios reports
Importance
Level 1
- Medicare will instead cover the drugs through a transitional programme from July until the end of 2027
- UnitedHealth (UNH), Eli Lilly (LLY), Novo Nordisk (NOVOB DC) and AHIP were cited around insurer concerns, beneficiary access and next steps
#UNITED STATES#USD#EUR#JAPAN#JPY#UNITED KINGDOM#GBP#EUROPE#ELI LILLY & CO#LLY.US#UNITEDHEALTH GROUP INC#UNH.US#NOVO NORDISK A/S#NOVOB.DC#FOREX#EQUITIES#ENERGY#EU SESSION#WTI#COMMODITIES#MANAGED HEALTH CARE#PHARMACEUTICALS#HEALTH CARE PROVIDERS & SERVICES#PHARMACEUTICALS (GROUP)#HEALTH CARE EQUIPMENT & SERVICES (GROUP)#PHARMACEUTICALS, BIOTECHNOLOGY & LIFE SCIENCES#S&P 500 INDEX#ELI LILLY AND CO#LLY#UNH#DXY#TRUMP#US EQUITIES